Evaluation of rotigotine transdermal patch in combination with low or high dose levodopa in patients with Parkinson’s disease: post-hoc analysis
Objective: To investigate the value of adding the dopamine agonist (DA) rotigotine (RTG) to low (<400mg/day) or high (≥400mg/day) levodopa (Ldopa) doses in patients with…A prospective randomized cross-over study of telemedicine system in Parkinson’s disease
Objective: To investigate the validity of telemedicine system in Parkinson’s disease(PD). Background: PD patients may be difficult to visit the hospitals because of decline of…Baseline characteristics of the population enrolled to a randomized clinical study of subcutaneous levodopa/carbidopa (ND0612) infusion in patients with advanced PD
Objective: To evaluate whether continuous 24 hours delivery of subcutaneous ND0612 offers practical and clinical benefits over continuous delivery over the waking day (14 hours).…Virtual research visits in individuals with Parkinson disease enrolled in a clinical trial: REACT-PD Study Interim Analysis
Objective: To demonstrate the feasibility, reliability, and value of conducting web-based clinical trial assessments in individuals with Parkinson disease (PD). Background: Increasing interest has been…Aerobic Exercise Combined with rTMS for Parkinson’s Disease: A Randomized Trial
Objective: To explore clinical and neuro-physiological outcomes of aerobic exercise combined with real Vs sham repetitive transcranial magnetic stimulation (rTMS) over motor cortex (M1) in…Gait Asymmetry and Parkinson’s Disease
Objective: To evaluate gait asymmetry using velocity-dependent gait analysis and compare to UPDRS asymmetries. Background: Motor impairment, including gait impairment, in patients with Parkinson’s disease…A prospective comparison of apomorphine, STN deep brain stimulation and levodopa-carbidopa intestinal gel therapy for motor fluctuations in PD
Objective: To compare the clinical, functional and quality of life (QoL) outcomes in patients with advanced Parkinson’s disease (PD) following treatment with apomorphine (APO), either…Patient Engagement in Parkinson’s Research: A Comparison of Attitudes and Impact in the UK and the US
Objective: To compare and contrast the attitudes and perceived impact of patient engagement on Parkinson’s research among patients, researchers and study sponsors in the UK…Using an Objective Measure of Movement to Quantify Night Time Sleep
Objective: To assess whether data obtained from the Parkinson’s KinetiGraph (PKG), an objective movement recording system for Parkinson’s disease (PD), could be used to provide…Patient perspectives of using the ND0612 mini-pump
Objective: To evaluate patient and caregiver usability and satisfaction with the mini-pump that will be used for continuous ND0612 delivery among patients with moderate-severe PD.…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.